Literature DB >> 9736551

In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides.

G Bergsson1, J Arnfinnsson, S M Karlsson, O Steingrímsson, H Thormar.   

Abstract

The antichlamydial effects of several fatty acids and monoglycerides were studied by incubating Chlamydia trachomatis bacteria with equal volumes of lipid solutions for 10 min and measuring the reduction in infectivity titer compared with that in a control solution without lipid. Caprylic acid (8:0), monocaprylin (8:0), monolaurin (12:0), myristic acid (14:0), palmitoleic acid (16:1), monopalmitolein (16:1), oleic acid (18:1), and monoolein (18:1) at concentrations of 20 mM (final concentration, 10 mM) had negligible effects on C. trachomatis. In contrast, lauric acid (12:0), capric acid (10:0), and monocaprin (10:0) caused a greater than 10,000-fold (>4-log10) reduction in the infectivity titer. When the fatty acids and monoglycerides were further compared at lower concentrations and with shorter exposure times, lauric acid was more active than capric acid and monocaprin was the most active, causing a greater than 100, 000-fold (>5-log10) inactivation of C. trachomatis at a concentration of 5 mM for 5 min. The high levels of activity of capric and lauric acids and particularly that of monocaprin are notable and suggest that these lipids have specific antichlamydial effects. The mode of action of monocaprin was further studied by removal of the lipid by centrifugation before inoculation of Chlamydia onto host cells and by electron microscopy. The results indicate that the bacteria are killed by the lipid, possibly by disrupting the membrane(s) of the elementary bodies. A 50% effective concentration of 30 microgram/ml was found by incubation of Chlamydia with monocaprin for 2 h. The rapid inactivation of large numbers of C. trachomatis organisms by monocaprin suggests that it may be useful as a microbicidal agent for the prevention of the sexual transmission of C. trachomatis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736551      PMCID: PMC105821     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Pathogenesis of pelvic inflammatory disease.

Authors:  L Weström; P Wölner-Hanssen
Journal:  Genitourin Med       Date:  1993-02

Review 2.  Challenges for the development of female-controlled vaginal microbicides.

Authors:  C J Elias; L L Heise
Journal:  AIDS       Date:  1994-01       Impact factor: 4.177

3.  Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides.

Authors:  H Thormar; C E Isaacs; H R Brown; M R Barshatzky; T Pessolano
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  The spermicide nonoxynol-9 does not inhibit Chlamydia trachomatis in vitro.

Authors:  E W Kappus; T C Quinn
Journal:  Sex Transm Dis       Date:  1986 Jul-Sep       Impact factor: 2.830

5.  A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections.

Authors:  W C Louv; H Austin; W J Alexander; S Stagno; J Cheeks
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

6.  Antimicrobial activity of lipids added to human milk, infant formula, and bovine milk.

Authors:  Charles E. Isaacs; Richard E. Litov; Halldor Thormar
Journal:  J Nutr Biochem       Date:  1995-07       Impact factor: 6.048

7.  Effect of antiviral lipids, heat, and freezing on the activity of viruses in human milk.

Authors:  J K Welsh; M Arsenakis; R J Coelen; J T May
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

Review 8.  Inactivation of enveloped viruses in human bodily fluids by purified lipids.

Authors:  C E Isaacs; K S Kim; H Thormar
Journal:  Ann N Y Acad Sci       Date:  1994-06-06       Impact factor: 5.691

9.  Virucides in prevention of HIV infection. Research Priorities. World Health Organization Working Group on Virucides.

Authors:  M J Rosenberg; K K Holmes
Journal:  Sex Transm Dis       Date:  1993 Jan-Feb       Impact factor: 2.830

10.  In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis.

Authors:  J P Kelly; R B Reynolds; S Stagno; W C Louv; W J Alexander
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

View more
  33 in total

1.  Stable concentrated emulsions of the 1-monoglyceride of capric acid (monocaprin) with microbicidal activities against the food-borne bacteria Campylobacter jejuni, Salmonella spp., and Escherichia coli.

Authors:  Halldor Thormar; Hilmar Hilmarsson; Gudmundur Bergsson
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis.

Authors:  L M Ballweber; J E Jaynes; W E Stamm; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides.

Authors:  G Bergsson; O Steingrímsson; H Thormar
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.

Authors:  Mark S Rouse; Margalida Rotger; Kerryl E Piper; James M Steckelberg; Matthew Scholz; Jeffrey Andrews; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria.

Authors:  Harry G Preuss; Bobby Echard; Mary Enig; Itzhak Brook; Thomas B Elliott
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

6.  Antimicrobial mechanism of monocaprylate.

Authors:  Morten Hyldgaard; Duncan S Sutherland; Maria Sundh; Tina Mygind; Rikke Louise Meyer
Journal:  Appl Environ Microbiol       Date:  2012-02-17       Impact factor: 4.792

7.  Anti-inflammatory and antioxidant effect of Kerabala: a value-added ayurvedic formulation from virgin coconut oil inhibits pathogenesis in adjuvant-induced arthritis.

Authors:  M Ratheesh; S Sandya; C Pramod; S Asha; Jose P Svenia; S Premlal; B GrishKumar
Journal:  Inflammopharmacology       Date:  2016-11-22       Impact factor: 4.473

8.  Angiogenic and wound healing potency of fermented virgin coconut oil: in vitro and in vivo studies.

Authors:  Ahmad H Ibrahim; Haibo Li; Sawsan S Al-Rawi; Aman Shah Abdul Majid; Omar Am Al-Habib; Xiaobo Xia; Amin Ms Abdul Majid; Dan Ji
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

9.  Effect of virgin coconut oil on properties of surimi gel.

Authors:  Asir Gani; Soottawat Benjakul; Pornpot Nuthong
Journal:  J Food Sci Technol       Date:  2017-11-01       Impact factor: 2.701

10.  In vitro killing of Candida albicans by fatty acids and monoglycerides.

Authors:  G Bergsson; J Arnfinnsson; H Thormar
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.